TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06521671

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Dynaloc implant
Description: Internal fixation with Dynaloc implant

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cannulated cancellous screws
Description: Internal fixation with two or three cannulated cancellous screws
Study: NCT05078944

Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham acupuncture
Description: Sham acupoints: SA1 (5 cun lateral to GV5), SA2 (5 cun lateral to GV4), SA3 (1 cun lateral to BL56).~After sterilization, pragmatic placebo needles with blunt tip (size 0.30 × 50 mm, Hwato brand, China) are used. When their tips are pressed against the skin through plastic rings, participants will feel a pricking sensation. The electric stimulator is applied to bilateral SA1 and SA2 with no current output. The mental wire has been cut off with a same outlook as the electroacupuncture group. Needles placed in SA3 will be manually rotated every 15 minutes. Each session lasts for 45 min.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Donepezil Hydrochloride
Description: Donepezil hydrochloride (5 mg/capsule, Weicai Pharmaceutical Co., Ltd, China) is to be taken 5 mg daily.
Study: NCT04937751

Intervention type: DIAGNOSTIC_TEST
Intervention: biomarkers
Description: galactomannan, betaDglucan, resistance markers
Study: NCT05078944

Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Donepezil Hydrochloride
Description: Donepezil hydrochloride (5 mg/capsule, Weicai Pharmaceutical Co., Ltd, China) is to be taken 5 mg daily.
Study: NCT06191705

Intervention type: DIAGNOSTIC_TEST
Intervention: QuickDASH
Description: Participants will be administered Urdu version of QuickDASH to collect data regarding Disabilities of Arm, Shoulder \& Hand twice with a time interval of 72 hours to determine validity and reliability.
Study: NCT05209282

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Video Based Action Observation
Description: Individuals in this group will receive video-based action observation training in addition to the conventional physiotherapy program.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Live Action Observation
Description: Individuals in this group will receive live action observation training in addition to the conventional physiotherapy program.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy program
Description: Individuals in this group will only receive a conventional physiotherapy program.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional physiotherapy program
Description: Individuals in this group will only receive a conventional physiotherapy program.

Intervention type: OTHER
Group type: OTHER
Intervention: Conventional physiotherapy program
Description: Individuals in this group will only receive a conventional physiotherapy program.
Study: NCT05001802

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: transverse scan, in-plane, posterior- anterior quadratus lumborum block
Description: transverse scan, in-plane, posterior- anterior quadratus lumborum block The patients will receive the transmuscular quadratus lumborum block before surgery using the transverse scan, in-plain, posterior to anterior approach. 0.6ml/kg 0.375% ropivacaine is injected when the correct needle location is confirmed.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: paramedian sagittal longitudinal scan, in-plane, caudal-cranial quadratus lumborum block
Description: The patients will receive the transmuscular quadratus lumborum block before surgery using the paramedic sagittal longitudinal scan, in-plain, caudal-cephalic approach.0.6ml/kg 0.375% ropivacaine is injected when the correct needle location is confirmed.
Study: NCT06437327

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrotherapy
Description: Hot pack for 10 minutes Interferential Current (IFC) for 10 minutes

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Electrotherapy
Description: Hot pack for 10 minutes Interferential Current (IFC) for 10 minutes
Study: NCT05233774

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allogeneic MSC
Description: An allogeneic bone marrow-derived medicinal signaling cell (MSC) formulation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allogeneic MSC
Description: An allogeneic bone marrow-derived medicinal signaling cell (MSC) formulation

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Allogeneic MSC
Description: An allogeneic bone marrow-derived medicinal signaling cell (MSC) formulation

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05350098

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Plant-protein Diets
Description: Participants will consume meals with 70% plant-based protein three times a day. Participants will be prohibited to have meals other than experimental diets and to drink milk and soy milk.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Control Diets
Description: Participants will consume meals with 50% plant-based protein three times a day. Participants will be prohibited to have meals other than experimental diets and to drink milk and soy milk.
Study: NCT06287359

Intervention type: OTHER
Intervention: individual interviews
Description: Qualitative research with individual interviews
Study: NCT04978493

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 706321
Description: BI 706321

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ustekinumab
Description: ustekinumab

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ustekinumab
Description: ustekinumab

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT06542094

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Deep Brain stimulation
Description: All subjects will receive bilateral surgical implantation of DBS system.
Study: NCT06276894

Intervention type: DEVICE
Group type: OTHER
Intervention: Motek C-Mill™ treadmill
Description: We will enroll 10 to 15 participants to participate in a VR treadmill training session while wearing an fNIRS cap.

Intervention type: OTHER
Group type: OTHER
Intervention: training session with and without VR wearing the fNIRS cap
Description: training session with and without VR wearing the fNIRS cap
Study: NCT05678218

Intervention type: PROCEDURE
Intervention: Endoscopic Ultrasound registration
Description: Registration of all findings during Endoscopic Ultrasound
Study: NCT05531539

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WELMO sensors vest
Description: Wearing of a vest equipped with lung auscultation and EIT sensors for signal acquisition and transmission

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WELMO sensors vest
Description: Wearing of a vest equipped with lung auscultation and EIT sensors for signal acquisition and transmission

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: WELMO sensors vest
Description: Wearing of a vest equipped with lung auscultation and EIT sensors for signal acquisition and transmission
Study: NCT04818346

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB054707
Description: INCB054707 will be administered once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB054707
Description: INCB054707 will be administered once daily

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: INCB054707
Description: INCB054707 will be administered once daily

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo or INCB054707 will be administered once daily
Study: NCT06171945

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AYA Connect intervention
Description: Participants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AYA Connect intervention
Description: Participants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: AYA Connect intervention
Description: Participants will receive a smart scale, activity tracker, an individual kickoff videochat session with a health coach, and access to a mobile smartphone app that includes weekly behavioral lessons, dietary tracking log, daily weight-related behavioral goals, tailored feedback summaries, and in-app health-related messages.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Psychology (PP) intervention
Description: Participants will receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Psychology (PP) intervention
Description: Participants will receive lessons about positive psychology (PP) strategies, weekly goals for PP exercises, and in-app health-related messages that include reminders to practice PP exercises.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Positive Psychology Plus (PP+) intervention
Description: Participants will receive weekly individual videochat sessions with a health coach.
Study: NCT05854381

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIR-1388
Description: VIR-1388 is given by subcutaneous injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIR-1388
Description: VIR-1388 is given by subcutaneous injection

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: VIR-1388
Description: VIR-1388 is given by subcutaneous injection

Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The HT Diluent Placebo is HT buffer (20 mM histidine, 10% trehalose-dihydrate, pH 7.2) and contains no active ingredient and will be administered by subcutaneous injection
Study: NCT05309161

Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Crassocephalum rabens extract
Description: dosage: a capsule (180 mg)/day; duration: 1 month

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Crassocephalum rabens extract
Description: dosage: a capsule (180 mg)/day; duration: 1 month
Study: NCT02540200

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: BST-CarGel
Description: BST-CarGel is a scaffolding material after microfracture treatment is performed in order to treat the chondral lesions. It assists in the repair process by stabilizing the clot in the cartilage lesion via adhesion and inhibition of clot retraction.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Microfracture
Description: It is a bone marrow stimulation technique, and the standard treatment for chondral lesions of the hip joint.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Microfracture
Description: It is a bone marrow stimulation technique, and the standard treatment for chondral lesions of the hip joint.
Study: NCT06486168

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: NIVATS
Description: Non-Intubated Video-Assisted Thoracic Surgery (NIVATS) is the least invasive approach available. It is part of an optimal Enhanced Recovery After Surgery (ERAS) pathway and allows for expanding surgical indications in patients with poor cardio-pulmonary function.
Study: NCT05851482

Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: High resolution manometry
Description: Standard chicago classification 4.0 HRM protocol
Study: NCT06098222

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Slow breathing exercise training
Description: Slow breathing exercise training will be given by the researcher in a single one-hour session in the meeting room of the unit 24 hours after the PCI and/or the next day. After a 20-minute silent rest in the training, patients will be asked to breathe slowly through the nostrils for 4 seconds and slowly exhale through the mouth for 6 seconds to reach 6-8 breaths/min. The patient will rest for 5 seconds after every 6 slow breaths. During the training period, a stopwatch will be used by observing the patient's chest and abdominal movements in order to determine whether the patients have reached the required respiratory rate.
Study: NCT06052852

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BDC-3042
Description: Dectin-2 agonist antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BDC-3042
Description: Dectin-2 agonist antibody

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cemiplimab
Description: Drug which blocks checkpoint proteins from binding with their partner proteins, allowing T cells to kill cancer cells
Study: NCT06336096

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suzetrigine
Description: Tablet(s) for oral administration.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Suzetrigine
Description: Tablet(s) and Suspension for oral administration.
Study: NCT06437327

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Active release technique
Description: Active release technique is applied (patient is prone lying with knee flexed, Pressure is applied on taut band and patient is asked to move the leg in internal rotation to achieve maximal lengthening) Repetitions 5 to 7 times hold for 5 to 20 seconds

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hold relax technique
Description: This technique is applied while the patient is in supine lying with one leg crossed over the other Patient is instructed to contract the piriformis against the manual resistance for 5 to 10 secs Then 15 secs of passive stretch is given repetitions x 5 times
Study: NCT06448845

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Arm intravenous regional anesthesia
Description: After placement of the upper arm and forearm tourniquets and exsanguination of the limb distal to the cuff by applying an Esmarch's bandage starting from the fingertips, the arm tourniquet cuff is inflated to a pressure of 250 mmHg. The double arm cuff pneumatic pressure tourniquet is placed immediately above the elbow crease and on the top of a circumferentially placed cotton cast padding before inflation. Subsequently, tourniquet failure is ruled out by observing the absence of distal circulation and 40 ml 0.5% lidocaine is slowly injected through the intravenous cannula on the dorsum of the hand. The tourniquet remained inflated for 60 minutes from injection of lidocaine to reduce the risk of local anesthetic systemic toxicity (LAST)

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Forearm IVRA block
Description: After placement of the forearm double tourniquet and exsanguination of the limb distal to the cuff by applying an Esmarch's bandage starting from the fingertips, the forearm tourniquet cuff is inflated to a pressure of 250 mmHg. The forearm tourniquet will be placed 5 cm distal to the medial epicondyle of the humerus and on the top of a circumferentially placed cotton cast. Subsequently, tourniquet failure is ruled out by observing the distal circulation and 25 ml 0.5% lidocaine is slowly injected through the intravenous cannula on the dorsum of the hand.
Study: NCT05589610

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EQ101
Description: EQ101, 2 mg/kg, once weekly dosing, for a total of 24 doses
Study: NCT05064488

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evobrutinib
Description: Participants will receive evobrutinib film-coated tablet, twice daily under fed conditions from Days 4 to 12 in Part 1 and from Days 2 to 8 in Part 2 of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Evobrutinib
Description: Participants will receive evobrutinib film-coated tablet, twice daily under fed conditions from Days 4 to 12 in Part 1 and from Days 2 to 8 in Part 2 of the study.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Digoxin
Description: Participants will receive digoxin tablet under fed conditions, once a day on Day 1 and Day 10 in Part 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metformin
Description: Participants will receive metformin oral solution under fed conditions, once a day on Day 1 and Day 10 in Part 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvastatin
Description: Participants will receive rosuvastatin tablet under fed conditions, once a day on Day 1 and Day 10 in Part 1.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sumatriptan
Description: Participants will receive sumatriptan tablet under fed conditions, once a day on Day 1 and Day 8 in Part 2.
Study: NCT06157489

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle
Study: NCT06479538

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post isometric relaxation
Description: 17 participants will be in experimental group A giving them Post isometric relaxation of Quadratus lumborum for four weeks, measuring all values before giving them protocol and after protocol.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Post facilitation stretching
Description: 17 participants will be in experimental group A giving them Post facilitation stretching of Quadratus lumborum for four weeks, measuring all values before giving them protocol and after protocol.
Study: NCT06157489

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle

Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Kinesio tape
Description: Kinesiotape is applied on masseter muscle, orbi and infrahyoid muscles for facilitating suprahyoid muscle
Study: NCT06530953

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Navigator Model
Description: The patient navigator model is an evidence-based intervention to improve access to healthcare services.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Patient Navigator Model
Description: The patient navigator model is an evidence-based intervention to improve access to healthcare services.
Study: NCT05647447

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Osanetant
Description: Osanetant 200 mg orally, twice per day
Study: NCT06536790

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: hang clean training
Description: This include hang clean training thrice a week for twelve weeks
Study: NCT05907369

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Active EC training
Description: The active EC includes pairing contamination-related pictures (CSs) with pleasant pictures (USs). The EC training takes about 15 minutes and is administered for ten sessions (5 days a week) in 4 difficulty levels.
Study: NCT06536790

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: half squat training
Description: This include half squat training thrice a week for twelve weeks
Study: NCT05526638

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: ultraviolet phototherapy
Description: thrice weekly sessions of ultraviolet phototherapy